London · Delayed Price · Currency is GBP · Price in GBX Diploma Earnings Call Transcripts
Fiscal Year 2026
-
Guidance for organic growth and margins has been upgraded, with earnings set to rise over 20%. Strong performance is seen across key segments, especially Controls and Peerless, while M&A momentum remains robust and margins are expected to stay at the higher end.
-
Q1 delivered 14% organic growth and strong acquisition momentum, with margins and guidance unchanged. Key segments like Peerless and Controls performed well, and the acquisition pipeline remains robust, supporting future growth.
Fiscal Year 2025
-
Strong double-digit revenue and earnings growth exceeded expectations, driven by organic expansion, disciplined acquisitions, and margin improvement. Outlook for FY2026 is positive, with continued investment in talent, end markets, and a robust acquisition pipeline supporting sustainable compounding.
-
Upgraded full-year organic growth guidance to 10% and reported strong revenue and margin performance. Recent acquisitions are expected to deliver high single-digit growth and synergies, while the long-term acquisition pipeline remains robust. Positive trends continue in key segments and markets.
-
Strong first-half results with 23% earnings growth, 9% organic revenue growth, and improved margins led to upgraded full-year guidance. Controls and Life Sciences segments outperformed, while Seals remained resilient. Robust cash flow, disciplined capital allocation, and a healthy acquisition pipeline support long-term growth.
-
Organic revenue grew 7% and reported revenue rose 12% in Q1, driven by strong Controls and Life Sciences segments, while Seals faced tougher industrial markets. Guidance remains unchanged, with management confident in medium- and long-term growth and a disciplined M&A approach.
Fiscal Year 2024
-
Delivered 6% organic and 14% reported revenue growth, with margins rising to 20.9% and EPS up 15%. Acquisitions and portfolio focus drove resilience, while 2025 guidance anticipates continued strong growth and margin expansion.
-
Q3 saw 13% reported and 6% organic revenue growth, with strong acquisition integration and robust margins above 17%. The outlook remains positive, with resilience across sectors and a strong M&A pipeline, despite ongoing industrial market challenges.